This Course has been retired COVID-19 Patients on High Velocity Nasal Insufflation
Considerations & Transmission Prevention
John Walsh presents the highly relevant course about "COVID-19 Patients on High Velocity Nasal Insufflation--Considerations and Transmission Prevention". In this course, you will:
- Review COVID-19 symptoms
- Review COVID-19 transmission risks
- Discuss HVNI in the context of COVID-19 management
Overview the proper protective measures to reduce transmission risk during HVNI
This course is AARC accredited for 1 CRCE under the Clinical Practice (CLP) category.
John Walsh is a Respiratory Therapist and currently holds the position of Area Vice President with Vapotherm.
Prior to this, he used HVNI on adult patients in the Emergency Department.
John has been with Vapotherm for 19 years, and in that time has helped hospitals all over the world, on implementing and using this therapy.
StartCourse Retirement Announcement
StartVideo Section 1: COVID-19 Introduction and Symptoms (5:19)
StartVideo Section 2: Transmission Risks (11:32)
StartVideo Section 3: Considerations for Using HVNI in COVID-19 Patients (9:47)
StartVideo Section 4: Reducing Transmission Risk When Using HVNI (6:44)
StartVideo Section 5: Summary (1:52)
StartVideo Section 6: Q&A Session (20:59)
StartQuiz: COVID-19 Patients on HVNI
StartEvaluation: COVID-19 Patients on HVNI